Komori
Mitsubishi Chemical Group (4188) · TargetRestated

Taiyo Nippon Sanso’s long-term vision of ¥1 trillion in revenue and a 10% operating margin

First written in FY2019-Q1. 2 of 4 entries say "Restated". Latest entry: FY2019.

4entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019-Q1 – FY2019-Q2AdvancedFY2019-Q32018: 220182019: 22019
Same theme, other companies
Achieving Revenue, EBITDA, and ROIC Targets under Vision 2030A theme 9 companies write about · 0 as a headwind · 9 as a tailwind

The whole theme swung hardest in 2025: 2 of 7 companies on the "Worse" side.

4 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2019RestatedAnnual report

    「大陽日酸㈱ aims to achieve a long-term management vision of revenue of ¥1 trillion, an operating margin of 10%, ROCE of 10% or more and an overseas revenue ratio of 50% or more in order to strengthen its global competitiveness and establish a firm position amid ongoing industry consolidation. The acquisition is viewed as an excellent investment opportunity with strategic significance, providing a major step toward achieving this vision.」

    The Company continues to position the acquisition of the European business and the US HyCO business as means of achieving its long-term management vision, including revenue of ¥1 trillion.
  2. FY2019-Q3AdvancedAnnual report

    「大陽日酸㈱ aims to achieve a long-term management vision of revenue of ¥1 trillion, an operating margin of 10%, ROCE of 10% or more and an overseas revenue ratio of 50% or more in order to strengthen its global competitiveness and establish a firm position amid ongoing industry consolidation. The acquisition is viewed as an excellent investment opportunity with strategic significance, providing a major step toward achieving this vision.」

    With respect to 大陽日酸's long-term management vision, the Company positioned the completed acquisition of Praxair's European business as having secured a certain share of business, manufacturing sites, personnel and a business platform in Europe.
  3. FY2019-Q2RestatedAnnual report

    「As our long-term management vision, we have set the targets of revenue of ¥1 trillion, an operating margin of 10%, ROCE of at least 10%, and an overseas revenue ratio of at least 50%. We regard this acquisition as an excellent investment opportunity with strategic significance, providing a major means of advancing toward realization of the vision.」

    大陽日酸 reaffirmed its long-term management vision and the positioning of the acquisition of Praxair's European business as a means of achieving it.
  4. FY2019-Q1First statedAnnual report

    「As its long-term management vision, the Company aims to achieve revenue of ¥1 trillion, an operating margin of 10%, ROCE of 10% or more and an overseas revenue ratio of 50% or more.」

    大陽日酸 has established a long-term management vision of revenue of ¥1 trillion, an operating margin of 10%, ROCE of 10% or more and an overseas revenue ratio of 50% or more. No specific target date for achievement was stated.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Mitsubishi Chemical Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.